Farmax India Limited announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2016. For the quarter, the company reported net total income from operations of INR 18.612 million against INR 57.984 million a year ago. Loss from operations before other income, provisions and exceptional items were INR 6.621 million against INR 16.222 million a year ago. Loss from ordinary activities before tax was INR 6.620 million against INR 15.650 million a year ago. Net loss after taxes, minority interest and share of profit of associates was INR 6.620 million or loss of INR 0.01 per basic and diluted share before and after extraordinary items not annualized against loss of INR 15.650 million or loss of INR 0.03 per basic and diluted share before and after extraordinary items not annualized a year ago. For the six months, the company reported net total income from operations of INR 41.761 million against INR 106.174 million a year ago. Loss from operations before other income, provisions and exceptional items were INR 17.264 million against INR 42.196 million a year ago. Loss from ordinary activities before tax was INR 16.833 million against loss of INR 40.790 million a year ago. Net loss after taxes, minority interest and share of profit of associates was INR 16.833 million or loss of INR 0.03 per basic and diluted share before and after extraordinary items not annualized against loss of INR 40.790 million or loss of INR 0.08 per basic and diluted share before and after extraordinary items not annualized a year ago.